Compare Stocks: OPCH, TEM, FMS, and DVA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVA DaVita	$178.29 +2.1%	$195.40	$101.00 ▼ $247.49	$11.38B	0.83	919,990 shs	519,840 shs
FMS Fresenius Medical Care AG & Co. KGaA	$22.70 +1.5%	$23.52	$20.02 ▼ $27.64	$12.19B	0.76	690,041 shs	532,835 shs
OPCH Option Care Health	$23.07 +0.6%	$23.43	$18.01 ▼ $36.80	$3.46B	0.61	2.47 million shs	1.17 million shs
TEM Tempus AI	$85.01 +3.4%	$58.96	$40.77 ▼ $104.32	$15.34B	3.72	6.17 million shs	8.42 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVA DaVita	-4.57%	-4.54%	-1.76%	-19.43%	+30.72%
FMS Fresenius Medical Care AG & Co. KGaA	-0.36%	+1.22%	-4.85%	-3.83%	-13.47%
OPCH Option Care Health	-1.71%	-6.37%	-2.96%	+5.13%	-16.58%
TEM Tempus AI	+7.38%	+2.34%	+19.66%	+46.49%	+3.80%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVA DaVita	$178.29 +2.1%	$195.40	$101.00 ▼ $247.49	$11.38B	0.83	919,990 shs	519,840 shs
FMS Fresenius Medical Care AG & Co. KGaA	$22.70 +1.5%	$23.52	$20.02 ▼ $27.64	$12.19B	0.76	690,041 shs	532,835 shs
OPCH Option Care Health	$23.07 +0.6%	$23.43	$18.01 ▼ $36.80	$3.46B	0.61	2.47 million shs	1.17 million shs
TEM Tempus AI	$85.01 +3.4%	$58.96	$40.77 ▼ $104.32	$15.34B	3.72	6.17 million shs	8.42 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVA DaVita	-4.57%	-4.54%	-1.76%	-19.43%	+30.72%
FMS Fresenius Medical Care AG & Co. KGaA	-0.36%	+1.22%	-4.85%	-3.83%	-13.47%
OPCH Option Care Health	-1.71%	-6.37%	-2.96%	+5.13%	-16.58%
TEM Tempus AI	+7.38%	+2.34%	+19.66%	+46.49%	+3.80%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DVA DaVita	2.57	Moderate Buy	$233.43	30.59% Upside
FMS Fresenius Medical Care AG & Co. KGaA	1.55	Reduce	$23.57	4.07% Upside
OPCH Option Care Health	2.50	Moderate Buy	$29.92	29.65% Upside
TEM Tempus AI	2.41	Hold	$69.63	-16.94% Downside

Current Analyst Ratings Breakdown

Latest OPCH, TEM, FMS, and DVA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/22/2026	OPCH Option Care Health	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/21/2026	TEM Tempus AI	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$75.00
9/21/2026	TEM Tempus AI	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$75.00
9/11/2026	OPCH Option Care Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
9/11/2026	TEM Tempus AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/11/2026	TEM Tempus AI	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$56.00 ➝ $66.00
9/9/2026	TEM Tempus AI	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$70.00
9/8/2026	TEM Tempus AI	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$67.00
9/8/2026	TEM Tempus AI	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$67.00
9/8/2026	TEM Tempus AI	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$67.00
9/2/2026	TEM Tempus AI	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$80.00

(Data available from 9/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DVA DaVita	$13.64B	0.84	$21.13 per share	8.46	($5.29) per share	-33.79
FMS Fresenius Medical Care AG & Co. KGaA	$22.20B	0.55	$5.61 per share	4.04	$28.93 per share	0.78
OPCH Option Care Health	$5.65B	0.61	$1.97 per share	11.70	$8.36 per share	2.76
TEM Tempus AI	$1.27B	11.89	N/A	N/A	$2.76 per share	30.37

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DVA DaVita	$746.80M	$12.22	14.60	10.36	0.48	6.05%	-217.63%	5.07%	11/4/2026 (Estimated)
FMS Fresenius Medical Care AG & Co. KGaA	$1.11B	$1.93	11.73	9.64	4.18	4.83%	9.28%	4.16%	11/3/2026 (Estimated)
OPCH Option Care Health	$207.59M	$1.33	17.35	12.21	1.38	3.68%	18.74%	7.25%	10/29/2026 (Estimated)
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	11/3/2026 (Estimated)

Latest OPCH, TEM, FMS, and DVA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2026	Q2 2026	DVA DaVita	$3.88	$4.02	+$0.14	$4.02	$3.50 billion	$3.55 billion
8/3/2026	Q2 2026	FMS Fresenius Medical Care AG & Co. KGaA	$0.6160	$0.66	+$0.0440	$0.46	$5.48 billion	$5.55 billion
7/30/2026	Q2 2026	TEM Tempus AI	-$0.1428	-$0.04	+$0.1028	$0.03	$379.69 million	$382.49 million
7/29/2026	Q2 2026	OPCH Option Care Health	$0.4263	$0.45	+$0.0237	$0.35	$1.42 billion	$1.44 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DVA DaVita	N/A	N/A	N/A	N/A	N/A
FMS Fresenius Medical Care AG & Co. KGaA	$0.61	2.69%	+2.66%	31.61%	N/A
OPCH Option Care Health	N/A	N/A	N/A	N/A	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DVA DaVita	N/A	1.47	1.41
FMS Fresenius Medical Care AG & Co. KGaA	0.43	1.07	0.75
OPCH Option Care Health	0.91	1.47	0.98
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DVA DaVita	90.12%
FMS Fresenius Medical Care AG & Co. KGaA	8.37%
OPCH Option Care Health	98.05%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
DVA DaVita	1.90%
FMS Fresenius Medical Care AG & Co. KGaA	N/A
OPCH Option Care Health	1.70%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DVA DaVita	78,000	63.80 million	62.59 million	Optionable
FMS Fresenius Medical Care AG & Co. KGaA	1,488	537.13 million	N/A	Optionable
OPCH Option Care Health	8,266	149.79 million	147.24 million	Optionable
TEM Tempus AI	3,800	180.43 million	136.66 million	N/A

OPCH, TEM, FMS, and DVA Headlines

Recent News About These Companies

Artificial Intelligence Stocks To Follow Today - September 25th

September 25 at 12:01 PM | marketbeat.com

Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research

September 25 at 9:48 AM | news-medical.netN

Tempus AI (TEM) Stock Soars 7% Despite CEO Cashing Out Millions

September 25 at 9:48 AM | coincentral.comC

Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock

September 25 at 5:22 AM | insidertrades.com

Top Artificial Intelligence Stocks To Research - September 23rd

September 25 at 1:01 AM | americanbankingnews.com

Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock

September 24 at 5:07 PM | marketbeat.com

Tempus AI (NASDAQ:TEM) Trading 6.1% Higher - Time to Buy?

September 24 at 3:39 PM | marketbeat.com

Top Performing Leveraged/Inverse ETFs: 09/20/2026

September 24 at 12:23 PM | etftrends.comE

Promising Artificial Intelligence Stocks To Consider - September 24th

September 24 at 12:01 PM | marketbeat.com

Tempus AI Chief Accounting Officer Sells $529,650 of Stock

September 24 at 9:04 AM | fool.com

Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4

September 24 at 8:26 AM | zacks.com

TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private Placement

September 24 at 4:00 AM | newsfilecorp.comN

Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test

September 22 at 5:31 PM | insidermonkey.com

3 Analysts, 3 Trades to Make Today

September 22 at 5:00 PM | investorplace.com

Tempus AI: High Risk, But With A Great Cause

September 22 at 8:00 AM | seekingalpha.com

Tempus AI (NASDAQ:TEM) Rating Increased to Hold at The Goldman Sachs Group

September 22 at 7:36 AM | americanbankingnews.com

Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating

September 22 at 7:29 AM | marketbeat.com

Tempus AI: Data And Applications Will Unlock More Upside

September 21, 2026 | seekingalpha.com

Tempus AI, Recursion Extend Data License, Amend Fee Structure

September 21, 2026 | finance.yahoo.com

Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion

September 21, 2026 | marketbeat.com

Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target

September 21, 2026 | marketscreener.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

OPCH, TEM, FMS, and DVA Company Descriptions

DaVita NYSE:DVA

$178.29 +3.62 (+2.07%)

Closing price 03:59 PM Eastern

Extended Trading

$177.98 -0.31 (-0.17%)

As of 05:20 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.70 +0.35 (+1.54%)

Closing price 03:59 PM Eastern

Extended Trading

$22.68 -0.01 (-0.04%)

As of 04:10 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Option Care Health NASDAQ:OPCH

$23.07 +0.13 (+0.57%)

Closing price 04:00 PM Eastern

Extended Trading

$23.06 0.00 (-0.02%)

As of 04:11 PM Eastern

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Tempus AI NASDAQ:TEM

$85.01 +2.77 (+3.37%)

Closing price 04:00 PM Eastern

Extended Trading

$84.68 -0.34 (-0.39%)

As of 05:28 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPCH, TEM, FMS, and DVA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPCH, TEM, FMS, and DVA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPCH, TEM, FMS, and DVA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

OPCH, TEM, FMS, and DVA Company Descriptions

DaVita NYSE:DVA

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Option Care Health NASDAQ:OPCH

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OPCH, TEM, FMS, and DVA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OPCH, TEM, FMS, and DVA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OPCH, TEM, FMS, and DVA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

OPCH, TEM, FMS, and DVA Company Descriptions

DaVita NYSE:DVA

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Option Care Health NASDAQ:OPCH

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools